Terkko Navigator / -/ Feeds / " ( ( Pravastatiini )|( PRAVASTATIN ORION )|( PRAVACHOL )|( PRAVASTATIN SANDOZ )|( PRAVABAS"

Vuoden pakolaisiksi valittiin kaksi tamperelaista

Ruoka- ja luonnonvaratilastointi tarkastelussa

The Clinical Pharmacogenetics Implementation Consortium Guideline for SLCO1B1, ABCG2, and CYP2C9 genotypes and Statin-Associated Musculoskeletal Symptoms

PRAVASTATIN SODIUM tablet [Glenmark Pharmaceuticals Inc., USA]

PRAVASTATIN SODIUM tablet [Apotex Corp.]

PRAVASTATIN SODIUM tablet [Teva Pharmaceuticals USA, Inc.]

PRAVASTATIN SODIUM tablet [Denton Pharma, Inc. DBA Northwind Pharmaceuticals]

PRAVASTATIN SODIUM tablet [A-S Medication Solutions]

PRAVASTATIN SODIUM tablet [Denton Pharma, Inc. DBA Northwind Pharmaceuticals]

PRAVASTATIN SODIUM tablet [Denton Pharma, Inc. DBA Northwind Pharmaceuticals]

PRAVASTATIN SODIUM tablet [Proficient Rx LP]

PRAVASTATIN SODIUM tablet [Proficient Rx LP]

PRAVASTATIN SODIUM tablet [Denton Pharma, Inc. DBA Northwind Pharmaceuticals]

Pravastatin Reduces Acute Phase Response of Zoledronic Acid

PRAVASTATIN SODIUM tablet [Proficient Rx LP]

PRAVASTATIN SODIUM tablet [REMEDYREPACK INC.]

PRAVASTATIN SODIUM tablet [REMEDYREPACK INC.]

PRAVASTATIN SODIUM tablet [REMEDYREPACK INC.]

Pravastatin-induced improvement in coronary reactivity and circulating ATP and ADP levels in young adults with type 1 diabetes.

Pravastatin-induced improvement in coronary reactivity and circulating ATP and ADP levels in young adults with type 1 diabetes.

Pravastatin-induced improvement in coronary reactivity and circulating ATP and ADP levels in young adults with type 1 diabetes.

Pravastatin-induced improvement in coronary reactivity and circulating ATP and ADP levels in young adults with type 1 diabetes.

Pravastatin-induced improvement in coronary reactivity and circulating ATP and ADP levels in young adults with type 1 diabetes.

Pravastatin-induced improvement in coronary reactivity and circulating ATP and ADP levels in young adults with type 1 diabetes.

Pravastatin-induced changes in expression of long non-coding and coding RNAs in endothelial cells.

Pravastatin Promotes Endothelial Colony-Forming Cell Function, Angiogenic Signaling and Protein Expression In Vitro.

Pravastatin-induced improvement in coronary reactivity and circulating ATP and ADP levels in young adults with type 1 diabetes

Pravastatin-induced improvement in coronary reactivity and circulating ATP and ADP levels in young adults with type 1 diabetes

Pravastatin attenuates sepsis-induced acute lung injury through decreasing pulmonary microvascular permeability via inhibition of Cav-1/eNOS pathway

Gels, Vol. 8, Pages 81: Formulation Development and Evaluation of Pravastatin-Loaded Nanogel for Hyperlipidemia Management

Applied Sciences, Vol. 12, Pages 431: Short-Term Effect of Wearing of Extended Depth-of-Focus Contact Lenses in Myopic Children: A Pilot Study

Biden: "Selkä seinää vasten" joutunut Putin on yhä vaarallisempi

Dotan 15,7 miljoonan euron pää­palkinto yllättäjälle – voitti 5 peliä selkä seinää vasten

Amazon deforestation tops 11,000 sq km in Brazil, reaching 12-year high

Acute effects of pravastatin on cholesterol synthesis are associated with SLCO1B1 (encoding OATP1B1) haplotype *17.

Pharmacokinetics and pharmacodynamics of pravastatin in pediatric and adolescent cardiac transplant recipients on a regimen of triple immunosuppression.

Effect of rifampicin on pravastatin pharmacokinetics in healthy subjects.

Pharmacokinetics and pharmacodynamics of pravastatin in children with familial hypercholesterolemia.

Gemfibrozil increases plasma pravastatin concentrations and reduces pravastatin renal clearance.

Serum noncholesterol sterols in children with heterozygous familial hypercholesterolemia undergoing pravastatin therapy.

Pharmacokinetics and response to pravastatin in paediatric patients with familial hypercholesterolaemia and in paediatric cardiac transplant recipients in relation to polymorphisms of the SLCO1B1 and ABCB1 genes.

SLCO1B1 polymorphism and sex affect the pharmacokinetics of pravastatin but not fluvastatin.

Association of genetic polymorphism in ABCC2 with hepatic multidrug resistance-associated protein 2 expression and pravastatin pharmacokinetics.

Association of genetic polymorphism in ABCC2 with hepatic multidrug resistance-associated protein 2 expression and pravastatin pharmacokinetics.

Effect of atorvastatin and pravastatin on platelet inhibition by aspirin and clopidogrel treatment in patients with coronary stent thrombosis.

Amiodarone Interacts with Simvastatin but not with Pravastatin Disposition Kinetics.

Effect of pravastatin treatment on Chlamydia pneumoniae infection, inflammation and serum lipids in NIH/S mice.

Coronary reactivity, homocysteine and methylenetetrahydrofolate reductase gene variation in young men during pravastatin therapy.

Coronary reactivity, homocysteine and methylenetetrahydrofolate reductase gene variation in young men during pravastatin therapy.

Coronary reactivity, homocysteine and methylenetetrahydrofolate reductase gene variation in young men during pravastatin therapy.